Target (CBDY) Short term Debt (2015 - 2026)

Target (CBDY) reported Short term Debt of $8100.0 for Q1 2026, down 55.9% year-over-year from $18369.0 in Q1 2025, and up 0.53% quarter-over-quarter from $8057.0 in Q4 2025.

Target (CBDY) Short term Debt (2015 - 2026) Analysis & Trends

Target (CBDY) has 12 years of Short term Debt data on file, last reported at $8100.0 in Q1 2026.

  • Short term Debt for Q1 2026 came in at $8100.0, down 55.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $8100.0 (down 55.9% YoY), and the FY2025 annual result was $8057.0, up 1.23% from the prior year.
  • Short term Debt climbed to $8100.0 in Q1 2026 per CBDY's latest filing, from $8057.0 in the prior quarter.
  • Over five years, Short term Debt peaked at $24159.0 in Q3 2023 and troughed at $7931.0 in Q1 2024.
  • A 5-year average of $11956.7 and a median of $10678.0 in 2022 frame the typical range for Short term Debt.
  • The sharpest annual moves came in 2024 and 2025: Short term Debt sank 66.99% in 2024, then jumped 131.61% in 2025.
  • A 5-year view of Short term Debt shows it stood at $15125.0 in 2022, then tumbled by 46.97% to $8021.0 in 2023, then slipped by 0.77% to $7959.0 in 2024, then increased by 1.23% to $8057.0 in 2025, then rose by 0.53% to $8100.0 in 2026.
  • Business Quant data shows CBDY's Short term Debt at $8100.0 in Q1 2026, $8057.0 in Q4 2025, and $7973.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Mar 31, 2026 8,100.00
Dec 31, 2025 8,057.00
Sep 30, 2025 7,973.00
Jun 30, 2025 10,285.00
Mar 31, 2025 18,369.00
Dec 31, 2024 7,959.00
Sep 30, 2024 7,974.00
Jun 30, 2024 16,170.00
Mar 31, 2024 7,931.00
Dec 31, 2023 8,021.00
Sep 30, 2023 24,159.00
Jun 30, 2023 16,318.00
Mar 31, 2023 12,454.00
Dec 31, 2022 15,125.00
Sep 30, 2022 10,678.00
Jun 30, 2022 12,421.00
Mar 31, 2022 11,270.00
Dec 31, 2021 7,902.00
Sep 30, 2021 10,518.00
Jun 30, 2021 11,133.00